•
PA
PACB
Pacific Biosciences of California, Inc.
yahooLABORATORY ANALYTICAL INSTRUMENTS
--
Price Chart
Market Cap
730.62M
Volume
8.31M
52W High
$2.73
52W Low
$0.85
Open
$0.00
Prev Close
$2.36
Day Range
0.00 - 0.00
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Latest News
Genomics Data Analysis Market Size to Surpass USD 28.74 Bn by 2034
GlobeNewswire Inc.•Oct 31
PacBio to Present at Upcoming Investor Conferences
GlobeNewswire Inc.•Aug 6
Long Read Sequencing Market Projected to Reach USD 6.98 Billion by 2032, Driven by Advances in Genomics and Precision Medicine – SNS Insider
GlobeNewswire Inc.•Jun 21
Metagenomics Market Size, Share, Forecast & Trends Analysis Report 2025: Market to Soar to $6.71 Billion by 2031, Driven by Agri Genomics and Genome Mapping
GlobeNewswire Inc.•May 14
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
GlobeNewswire Inc.•May 12
PacBio Grants Equity Incentive Award to New Employee
GlobeNewswire Inc.•Feb 15
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
GlobeNewswire Inc.•Jan 20
Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and Early Detection Drive Robust Uptake of Neurogenomics Solutions
GlobeNewswire Inc.•Jan 15